The genomics revolution and the introduction of specialized technologies throughout the product development chain are transforming the economics of pharmaceutical R&D. As these advances become manifest, drug development becomes faster, more predictable and less expensive. Swedish access to these technologies helps boost efficiency and success in almost every stage of the product development cycle.
To learn more about trade with Sweden, visit > SwedenBIO